Hydrochlorothiazide Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 12.5 mg, 25 mg, 50 mg
Reference Brands: Microzide, HydroDiuril(US)
Category:
Medical Aid
Hydrochlorothiazide tablets are thiazide diuretics that increase urine output by inhibiting sodium reabsorption in the kidneys. Benefits include lowering blood pressure, reducing edema, and preventing heart failure complications. They help control hypertension, decrease fluid buildup, and promote cardiovascular health by reducing strain on the heart.
Hydrochlorothiazide Tablets is available in Tablet
and strengths such as 12.5 mg, 25 mg, 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hydrochlorothiazide Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hydrochlorothiazide Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hydrochlorothiazide tablets are approved in both the US and EU, supported by detailed dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP standards. In the US, regulatory oversight is provided by the FDA, while the EU’s EMA oversees approval processes. These dossiers include clinical trial data, stability, and safety profiles. Hydrochlorothiazide is widely prescribed for hypertension and edema management, obtaining market authorization after rigorous evaluation. For comprehensive licensing information, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Stay informed on regulatory requirements and market access pathways for hydrochlorothiazide products globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing